跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
diquafosol sodium
首页
药物
diquafosol sodium
diquafosol sodium
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
OPHTHALMIC COMPOSITION CONTAINING DIQUAFOSOL OR SALT THEREOF, VINYL-BASED POLYMER AND CELLULOSE-BASED POLYMER
US 2022054520 A1
申请人: SANTEN PHARMACEUTICAL CO LTD
优先权: 2019
CN
EP
US
WO
4 件公开
DIQUAFOSOL OR SALT THEREOF, AND AQUEOUS OPHTHALMIC COMPOSITION CONTAINING POLYVINYLPYRROLIDONE
WO 2021039748 A1
申请人: SANTEN PHARMACEUTICAL CO LTD
优先权: 2019
CN
WO
3 件公开
Compound diquafosol tetrasodium eye drops and preparation method thereof
CN 113712909 A
申请人: NANJING DICHANG PHARMACEUTICAL TECH CO LTD
优先权: 2020
CN
Preservative-free low-irritation single-dose packaged diquafosol sodium eye drops and preparation method thereof
CN 114246826 A
申请人: SHANGHAI ROOTING MEDICINE SCIENCE AND TECH LIMITED COMPANY
优先权: 2020
CN
Contact lens containing diquafosol sodium and preparation method of contact lens
CN 112156065 A
申请人: UNIV CHINA PHARMA
优先权: 2020
CN
Diquafosol sodium composition, preparation and preparation method of diquafosol sodium composition
CN 112691080 A
申请人: NANJING HENGDAO PHARMACEUTICAL TECH CO LTD
优先权: 2021
CN
Eye drop and preparation method thereof
CN 113712910 A
申请人: GUANGZHOU TOSUN PHARMACEUTICAL CO LTD
优先权: 2021
CN
Diquafosol sustained-release gel as well as preparation method and application thereof
CN 114191378 A
申请人: WENZHOU MEDICAL UNIV AFFILIATED EYE VISION LIGHT HOSPITAL
优先权: 2021
CN
Medicinal composition containing diquafosol sodium and preparation method thereof
CN 116265010 A
申请人: NANJING COMER BIOMEDICAL CO LTD
优先权: 2021
CN
Diquafosol sodium eye drops and preparation method thereof
CN 114306228 A
申请人: SHANDONG NOMINGKANG INSTITUTE OF DRUG RES CO LTD
优先权: 2022
CN
CN 117100695 A
申请人: SICHUAN MEDCO HUAKANG PHARMACEUTICAL CO LTD
优先权: 2023
CN
CN 119970633 A
申请人: SUZHOU LEZHU PHARMACEUTICAL CO LTD
优先权: 2025
CN
CN 120938923 A
申请人: WUHAN WUJING MEDICINE CO LTD
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈